State-of-the-Art Molecular Oncology in Brazil-Reference-Cited by-同舟云学术

State-of-the-Art Molecular Oncology in Brazil

Published:2023-05-29 Issue:11 Volume:24 Page:9452
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Rodrigues Tiago¹^ORCID

Affiliation:

1. Centro de Ciências Naturais e Humanas (CCNH), Universidade Federal do ABC (UFABC), Santo André 09210-580, Brazil

Abstract

Over the past few decades, the life expectancy of humankind has increased significantly due to advancements in life sciences and medical research, particularly given our increasing success in the epidemiological and pharmacological management of bacterial, fungi, and viral infections [...]

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

https://www.mdpi.com/1422-0067/24/11/9452/pdf

Reference16 articles.

1. Hallmarks of cancer: The next generation;Hanahan;Cell,2011

2. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review);Schirrmacher;Int. J. Oncol.,2019

3. De Campos, N.S.P., De Oliveira Beserra, A., Pereira, P.H.B., Chaves, A.S., Fonseca, F.L.A., Da Silva Medina, T., Dos Santos, T.G., Wang, Y., Marasco, W.A., and Suarez, E.R. (2022). Immune Checkpoint Blockade via PD-L1 Potentiates More CD28-Based than 4-1BB-Based Anti-Carbonic Anhydrase IX Chimeric Antigen Receptor T Cells. Int. J. Mol. Sci., 23.

4. Advancing CAR T cell therapy through the use of multidimensional omics data;Yang;Nat. Rev. Clin. Oncol.,2023

5. Crocamo, S., Binato, R., Dos Santos, E.C., De Paula, B., and Abdelhay, E. (2022). Translational Results of Zo-NAnTax: A Phase II Trial of Neoadjuvant Zoledronic Acid in HER2-Positive Breast Cancer. Int. J. Mol. Sci., 23.